Scioto Biosciences

Acquired

Scioto Biosciences is a biotech company in Indianapolis, United States, founded in 2017. It has raised $30.6M across 3 rounds, most recently a $26.5M Series B in August 2020.

Healing the Gut-Brain Axis

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$30.6M
Last Round
$26.5M Series BAug 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Scioto Biosciences is a clinical-stage biotechnology company developing microbiome-derived therapeutics targeting the gut-brain axis to treat serious neurological and neurodevelopmental disorders. The company's pipeline focuses on conditions with high unmet need including autism spectrum disorder (ASD), Fragile X syndrome, and related conditions. Scioto's approach leverages proprietary microbial strains and formulations that modulate neuroactive metabolites produced by the gut microbiome, aiming to improve behavioral and cognitive outcomes in patients where existing treatments are limited. Founded in 2018 and headquartered in Indianapolis, Indiana, the company has received funding to advance its pipeline toward clinical trials.

Summary

It lists 1–10 employees. It has raised $30.6M in total across 3 rounds, most recently a $26.5M Series B round in Aug 2020. Investors include Genome & Company and Plug and Play.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BAug 2020
$26.5M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Scioto Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/scioto-biosciences"><img src="https://indexed.vc/api/badge/company/scioto-biosciences" alt="Scioto Biosciences on Indexed.vc" width="260" height="76" /></a>